Compare Enveric Biosciences Inc (ENVB) vs SoundHound AI Inc (SOUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs SoundHound AI Inc — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.80M), while SoundHound AI Inc trades at $5.6 (market cap $2.45B). The key difference: SoundHound AI Inc is far larger — about 360.3× Enveric Biosciences Inc's market cap, and Enveric Biosciences Inc is more actively traded (64,867 versus 16,881,989). Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and SoundHound AI Inc for 23 Days on average.
| ENVB | SOUN | |
|---|---|---|
Market Cap | $6.80M | $2.45B |
Volume | 64,867 | 16,881,989 |
Sector | Health | Technology |
52-Week High | $10.80 | $21.40 |
52-Week Low | $1.27 | $5.52 |
Typical Hold Time | 14 Days | 23 Days |
Enterprise Value | -$1.49M | $2.25B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.495 with a 1.7% daily gain, showing technical bearish signals despite recent earnings beats. The company reported no revenue in 2025 with significant losses (-$8.77M net income), though valuation metrics appear low (EV/EBITDA 0.17, P/B 0.84). Recent news highlights patent approvals and positive preclinical data for non-hallucinogenic therapeutics.
The outlook remains speculative given the lack of revenue and substantial losses, offset by strong analyst support (75% buy rating) and promising drug development progress. Key risks include funding needs and clinical trial outcomes, while institutional sentiment appears cautiously optimistic about long-term pipeline potential.
SoundHound AI (SOUN) trades at $5.63, down 1.57% today, with a bearish technical signal despite recent earnings beats. The company shows strong revenue growth ($169M in 2025, projected $203M in 2026) but significant net losses (-$14M in 2025, -$137M projected in 2026). Recent developments include expansion into banking AI agents and the OASYS Edge embedded architecture launch for vehicles and smart devices (GlobeNewsWire, September 24, 2026).
Investment outlook balances high growth potential against substantial profitability challenges. Analyst consensus is bullish with a $9.33 price target (75% buy ratings), but negative cash flow from operations and insider selling pose near-term risks. The stock's success depends on converting revenue growth to profitability while managing integration risks from acquisitions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About SoundHound AI Inc
SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →
